Price
$1.60
Increased by +1.27%
Dollar volume (20D)
667.55 K
ADR%
11.62
Earnings report date
Aug 12, 2025
Shares float
15.67 M
Shares short
1.74 M [11.13%]
Shares outstanding
19.49 M
Market cap
30.20 M
Beta
1.45
Price/earnings
N/A
20D range
1.17 1.75
50D range
1.11 2.07
200D range
1.11 11.69

Annovis Bio, Inc., a clinical stage drug platform company, develops drugs to treat neurodegeneration in the United States.

The company's lead product candidate is Buntanetap, which is in phase 2/3 to treat alzheimer's disease, as well as in phase 3 to treat parkinson's disease; and is in phase 2 clinical trial to treat lewy body dementia.

It also develops ANVS405, which is in phase 2 and 3 clinical trials for the treatment of traumatic brain injury and/or stroke; and ANVS301, which finished phase 1 clinical trial to treat later stages of alzheimer's disease and dementia.

The company was incorporated in 2008 and is headquartered in Malvern, Pennsylvania.

  • Quarterly earnings
  • Annual earnings
Reported date EPSChange YoY EstimateSurprise
Mar 27, 25 -0.43
Increased by +80.80%
-0.20
Decreased by -115.00%
Nov 6, 24 -0.97
Increased by +40.49%
-0.53
Decreased by -83.02%
Aug 14, 24 -0.32
Increased by +70.09%
-0.63
Increased by +49.21%
May 10, 24 -0.72
Increased by +39.50%
-0.80
Increased by +10.00%
Mar 29, 24 -2.24
Decreased by -113.33%
-1.30
Decreased by -72.31%
Nov 8, 23 -1.63
Decreased by -75.27%
-1.09
Decreased by -49.54%
Aug 14, 23 -1.07
Increased by 0.00%
-1.14
Increased by +6.14%
May 10, 23 -1.19
Decreased by -65.28%
-0.33
Decreased by -260.61%
  • Quarterly financials
  • Annual financials
Fiscal ending date RevenueChange YoY IncomeChange YoY ProfitChange YoY
Dec 31, 24 0.00
Decreased by N/A%
-5.86 M
Increased by +73.60%
Decreased by N/A%
Decreased by N/A%
Sep 30, 24 0.00
Decreased by N/A%
-12.64 B
Decreased by -85.78 K%
Decreased by N/A%
Decreased by N/A%
Jun 30, 24 0.00
Decreased by N/A%
-5.02 M
Increased by +47.36%
Decreased by N/A%
Decreased by N/A%
Mar 31, 24 0.00
Decreased by N/A%
-1.07 M
Increased by +96.38%
Decreased by N/A%
Decreased by N/A%
Dec 31, 23 0.00
Decreased by N/A%
-22.21 M
Decreased by -635.39%
Decreased by N/A%
Decreased by N/A%
Sep 30, 23 0.00
Decreased by N/A%
-14.72 M
Decreased by -95.81%
Decreased by N/A%
Decreased by N/A%
Jun 30, 23 0.00
Decreased by N/A%
-9.54 M
Decreased by -10.31%
Decreased by N/A%
Decreased by N/A%
Mar 31, 23 0.00
Decreased by N/A%
-29.44 M
Decreased by -402.90%
Decreased by N/A%
Decreased by N/A%
Open dropdown content
Open dropdown content
DAILY
WEEKLY
MONTHLY